Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2026 Publisher: AstraZeneca UK Limited, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK
Crestor 10 mg film-coated tablets.
| Pharmaceutical Form |
|---|
|
Round, pink coloured tablets, intagliated with 'ZD4522' and '10' on one side and plain on the reverse. |
Each tablet contains 10 mg rosuvastatin (as rosuvastatin calcium). Each tablet contains 91.3 mg lactose monohydrate.
For a full list of excipients, see section 6.1.
| Active Ingredient |
|---|
|
Rosuvastatin is a selective and competitive inhibitor of HMG-CoA reductase. Rosuvastatin increases the number of hepatic LDL receptors on the cell-surface, enhancing uptake and catabolism of LDL and it inhibits the hepatic synthesis of VLDL, thereby reducing the total number of VLDL and LDL particles. |
| List of Excipients |
|---|
|
Tablet core: Lactose monohydrate Tablet coat: Lactose monohydrate |
Blisters of aluminium laminate/aluminium foil of 7, 14, 15, 20, 28, 30, 42, 50, 56, 60, 84, 90, 98 and 100 tablets
HDPE containers: 30 and 100 tablets.
Not all pack sizes may be marketed.
AstraZeneca UK Limited, 1 Francis Crick Avenue, Cambridge, CB2 0AA, UK
PL 17901/0201
21st March 2003/6th November 2012
| Drug | Countries | |
|---|---|---|
| CRESTOR | Austria, Australia, Brazil, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Ireland, Israel, Italy, Japan, Lithuania, Malta, Mexico, Nigeria, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.